This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Peptide Technology Limited, Other. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 14 
1 out of 834,453 Years Active: 2001-2002
Title: **Innovator Spotlight: Christopher John Easton**
Introduction
Christopher John Easton, a talented inventor based in Weetangera, Australia, has made significant contributions to the field of pharmaceuticals through his innovative approaches to fatty acid compounds. Holding two patents to date, his work underscores the importance of polyunsaturated fatty acids in medical applications.
Latest Patents
Easton's latest patents focus on modified polyunsaturated fatty acids, which exhibit notable antimalarial properties and also stimulate neutrophil activity. His patented compounds are characterized by a carbon chain length of 18-25 carbons and feature 1-6 double bonds. The modifications involve substitutions such as β-oxa, γ-oxa, β-thia, and γ-thia, demonstrating Easton's commitment to enhancing the efficacy of fatty acid derivatives. Additionally, he describes methods for ameliorating inflammation through the use of hydroxy, hydroperoxy, or peroxy derivatives of these fatty acids. His second patent presents an innovative approach to treating T-cell mediated diseases, leveraging polyunsaturated fatty acids in compositions that are coupled with pharmaceutical carriers for therapeutic applications.
Career Highlights
Throughout his career, Christopher John Easton has collaborated with reputable organizations, contributing invaluable research and development insights. Among his professional affiliations, he has been associated with Peptide Technology Limited, where he has furthered his work on fatty acids and their practical applications in medicine.
Collaborations
Easton has worked alongside esteemed colleagues, including Antonio Ferrante and Alfred Poulos, who have undoubtedly enriched his research outcomes and contributed to the successful trajectory of his innovative endeavors.
Conclusion
Christopher John Easton's inventive contributions to the field of modified polyunsaturated fatty acids highlight the potential for advancements in medical treatment through innovative chemistry. His patents reflect a deep understanding of the intersection between biology and chemistry, paving the way for future innovations in pharmacology and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile